GSK’s John Fleming on rethinking oncology from the ground upWhat if we could look at cancer treatment from a completely fresh perspective? This is the philosophy GSK’s Share XGSK’s John Fleming on rethinking oncology from the ground uphttps://deep-dive.pharmaphorum.com/magazine/future-of-oncology-2020/gsks-john-fleming-on-rethinking-oncology-from-the-ground-up/
Commercialising innovative new medicinesAs pharmaceutical ingenuity hits new heights, ensuring that patients gain access to innovative medicines requires a unique combination Share XCommercialising innovative new medicineshttps://deep-dive.pharmaphorum.com/magazine/future-of-oncology-2020/commercialising-innovative-new-medicines/
How to increase haematologists’ and oncologists’ confidence with new treatmentsA new whitepaper from Medscape highlights the difficulties haematologists and oncologists face in keeping up with rapid developments Share XHow to increase haematologists’ and oncologists’ confidence with new treatmentshttps://deep-dive.pharmaphorum.com/magazine/future-of-oncology-2020/how-to-increase-haematologists-and-oncologists-confidence-with-new-treatments/
Clinical decision support tools will help oncologists manage complexityMaking treatment decisions is a tough choice for oncologists: a therapy might save or significantly extend one patient’s Share XClinical decision support tools will help oncologists manage complexityhttps://deep-dive.pharmaphorum.com/magazine/future-of-oncology-2020/clinical-decision-support-tools-will-help-oncologists-manage-complexity/
Solving immuno-oncology trial challenges in the COVID-19 eraThe COVID-19 pandemic has placed immense stress on healthcare provision, but the emergency may also make major advances Share XSolving immuno-oncology trial challenges in the COVID-19 erahttps://deep-dive.pharmaphorum.com/magazine/future-of-oncology-2020/solving-immuno-oncology-trial-challenges-in-the-covid-19-era/
Making it as an oncology biotech in the UKWe speak to R&D experts to find out how oncology biotechs can get the support they need to Share XMaking it as an oncology biotech in the UKhttps://deep-dive.pharmaphorum.com/magazine/future-of-oncology-2020/alderley-park-oncology-biotech-uk/
Helping HCPs navigate the ever-evolving advanced cancer landscapeOPEN Health’s Christine Drewienkiewicz, Sara Black and Annie Rankin on advances in modern oncology and how pharma can Share XHelping HCPs navigate the ever-evolving advanced cancer landscapehttps://deep-dive.pharmaphorum.com/magazine/future-of-oncology-2020/helping-hcps-navigate-the-ever-evolving-advanced-cancer-landscape/
Adapting for the future of oncologyExternal pressures and rapid scientific advancements are changing oncology forever, and innovative trials are needed to keep pace. Share XAdapting for the future of oncologyhttps://deep-dive.pharmaphorum.com/magazine/future-of-oncology-2020/adapting-future-oncology-icon/
ASCO 2020: Scientific advances & what’s impacting doctors and patientsDespite going virtual due to the COVID-19 pandemic, Jennifer Harris, an immuno-oncology expert from Syneos Health told pharmaphorum’s Share XASCO 2020: Scientific advances & what’s impacting doctors and patientshttps://deep-dive.pharmaphorum.com/magazine/future-of-oncology-2020/asco-2020-scientific-advances-and-the-impact-on-doctors-and-patients/
